ICON Public Limited Company (ICLR)

Market Cap	11.73B
Revenue (ttm)	8.28B
Net Income (ttm)	791.47M
Shares Out	80.76M
EPS (ttm)	9.53
PE Ratio	15.40
Forward PE	10.70
Dividend	n/a
Ex-Dividend Date	n/a

Volume	703,612
Open	147.17
Previous Close	146.74
Day's Range	143.83 - 147.83
52-Week Range	138.51 - 347.72
Beta	1.24
Analysts	Buy
Price Target	225.55 (+55.24%)
Earnings Date	Apr 30, 2025

About ICLR

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: May 15, 1998
• Employees: 41,900
• Stock Exchange: NASDAQ
• Ticker Symbol: ICLR
• Website: https://www.iconplc.com

Financial Performance

In 2024, ICLR's revenue was $8.28 billion, an increase of 1.99% compared to the previous year's $8.12 billion. Earnings were $791.47 million, an increase of 29.26%.

Analyst Forecast

According to 12 analysts, the average rating for ICLR stock is "Buy." The 12-month stock price forecast is $225.55, which is an increase of 55.24% from the latest price.

Price Target

$225.55

(55.24% upside)

Analyst Consensus: Buy